title: Relative biological effectiveness (RBE) of thermal neutron capture therapy of cultured B-16 melanoma cells preincubated with 10B-paraboronophenylalanine.
abstract: An experimental study of the relative biological effectiveness (RBE) of thermal neutron capture therapy (TNCT) for melanoma cell inactivation using 10B1-paraboronophenylalanine (10B1-BPA) was carried out to demonstrate a high therapeutic effect of TNCT, compared with that of fast neutron. Cells preincubated with or without 10B1-BPA at a concentration of 50 micrograms/ml for 20 h were irradiated with 60Co gamma-ray, fast neutron or thermal neutron. The absorbed dose of the cells from thermal neutron was calculated by Kobayashi's model. The D0 value of fast neutron was 1.07 Gy, and the D0S of thermal neutron radiation with or without preincubation of the cells with 10B1-BPA were 0.46 Gy or 0.67 Gy, respectively. The RBEs of fast neutron, thermal neutron beams, and neutron capture therapy relative to 60Co gamma-ray were calculated as 2.78, 4.18, and 6.15 at 0.1 surviving fraction, respectively. These results indicate radiologically that thermal neutron capture therapy using 10B1-BPA is an excellent radiation therapy for malignant melanoma.
authors: Department of Dermatology, Kobe University School of Medicine, Japan.
authors: M
authors: M
authors: Ichihashi
authors: A
authors: A
authors: Sasase
authors: T
authors: T
authors: Hiramoto
authors: Y
authors: Y
authors: Funasaka
authors: S
authors: S
authors: Hatta
authors: Y
authors: Y
authors: Mishima
authors: T
authors: T
authors: Kobayashi
authors: H
authors: H
authors: Fukuda
authors: K
authors: K
authors: Yoshino
mesh_terms: D000818:Animals; D001896:Boron Compounds / Q000378:metabolism / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007554:Isotopes; D008545:Melanoma / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D008546:Melanoma, Experimental / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D009502:Neutrons; D010649:Phenylalanine / Q000378:metabolism / Q000494:pharmacology / Q000031:analogs & derivatives; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D014407:Tumor Cells, Cultured / Q000378:metabolism / Q000473:pathology / Q000528:radiation effects
chemical_list: D001896:Boron Compounds; D007554:Isotopes; D010649:Phenylalanine; C033685:4-boronophenylalanine